OMBYNCA
DEAD

Serial Number

97312749

Owner

Eli Lilly and Company

Attorney

Bruce W. Longbottom

Filing Date

Mar 15, 2022

Add to watchlist:

No watchlists yet
View on USPTO

OMBYNCA Trademark

Serial Number: 97312749

OMBYNCA is a trademark filed by Eli Lilly and Company on March 15, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Eli Lilly and Company (46 trademarks)

Lilly Corporate Center
Indianapolis, IN 46285

Entity Type: 03

Trademark Details

Filing Date

March 15, 2022

Registration Date

Not Registered

Published for Opposition

January 17, 2023

Goods & Services

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 20, 2026 MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 20, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 20, 2026 ABN6
ABANDONMENT - NO USE STATEMENT FILED
Apr 20, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 31, 2025 EXRA
SOU EXTENSION 5 GRANTED
Dec 31, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 30, 2025 AITU
SOU EXTENSION 5 FILED
Aug 15, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 18, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 18, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 18, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 15, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 15, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 15, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 15, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 20, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 19, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 19, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 19, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 17, 2023 EXRA
SOU EXTENSION 1 GRANTED
Aug 15, 2023 EX1G
SOU EXTENSION 1 FILED
Aug 15, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 15, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 14, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2022 CNSA
ASSIGNED TO EXAMINER
Dec 12, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2022 NWOS
NEW APPLICATION ENTERED
Mar 18, 2022 NWAP